2021
DOI: 10.1007/s10067-020-05568-5
|View full text |Cite
|
Sign up to set email alerts
|

Dermatomyositis: immunological landscape, biomarkers, and potential candidate drugs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 55 publications
0
1
0
Order By: Relevance
“…In 2018, Shuoshan Xie et al discovered that IFITM2, LY6E, DDX58, and IFI6 were expressed at higher levels in the muscle tissue of patients with DM, indicating the important role of the interferon (IFN) signaling pathway in the pathogenesis of DM [ 11 ]. In 2020, one bioinformatic study has concluded that DEGs between DM and healthy control (HC) are primarily enriched in immune-related pathways [ 12 ]. Another bioinformatic study has revealed 10 hub genes, including ISG15, DDX58, IFIT3, CXCL10, and STAT1, and indicated that proinflammatory factors and IFN family proteins are highly associated with DM [ 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…In 2018, Shuoshan Xie et al discovered that IFITM2, LY6E, DDX58, and IFI6 were expressed at higher levels in the muscle tissue of patients with DM, indicating the important role of the interferon (IFN) signaling pathway in the pathogenesis of DM [ 11 ]. In 2020, one bioinformatic study has concluded that DEGs between DM and healthy control (HC) are primarily enriched in immune-related pathways [ 12 ]. Another bioinformatic study has revealed 10 hub genes, including ISG15, DDX58, IFIT3, CXCL10, and STAT1, and indicated that proinflammatory factors and IFN family proteins are highly associated with DM [ 13 ].…”
Section: Introductionmentioning
confidence: 99%